CVS * Stock Overview
CVS Health Corporation provides health solutions in the United States.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1,170.00 |
52 Week High | US$1,400.00 |
52 Week Low | US$1,110.50 |
Beta | 0.51 |
1 Month Change | -11.61% |
3 Month Change | -7.25% |
1 Year Change | -4.94% |
3 Year Change | -30.48% |
5 Year Change | 8.84% |
Change since IPO | 194.35% |
Recent News & Updates
Recent updates
Shareholder Returns
CVS * | MX Healthcare | MX Market | |
---|---|---|---|
7D | 0.9% | 4.4% | 0.2% |
1Y | -4.9% | 6.1% | 1.9% |
Return vs Industry: CVS * underperformed the MX Healthcare industry which returned 6.1% over the past year.
Return vs Market: CVS * underperformed the MX Market which returned 1.9% over the past year.
Price Volatility
CVS * volatility | |
---|---|
CVS * Average Weekly Movement | 3.6% |
Healthcare Industry Average Movement | 5.5% |
Market Average Movement | 4.0% |
10% most volatile stocks in MX Market | 6.2% |
10% least volatile stocks in MX Market | 1.9% |
Stable Share Price: CVS * has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS *'s weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
CVS * fundamental statistics | |
---|---|
Market cap | Mex$1.45t |
Earnings (TTM) | Mex$124.64b |
Revenue (TTM) | Mex$6.13t |
9.7x
P/E Ratio0.2x
P/S RatioIs CVS * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVS * income statement (TTM) | |
---|---|
Revenue | US$359.78b |
Cost of Revenue | US$307.32b |
Gross Profit | US$52.46b |
Other Expenses | US$45.14b |
Earnings | US$7.32b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.81 |
Gross Margin | 14.58% |
Net Profit Margin | 2.03% |
Debt/Equity Ratio | 86.5% |
How did CVS * perform over the long term?
See historical performance and comparison